EWSR1 and rhabdomyosarcoma: A recent preclinical study tested the efficacy of a drug-conjugated anti-B7-H3 antibody in patient-derived and cell line-derived xenografts of EWS, rhabdomyosarcoma, Wilms’ tumors, osteosarcoma and NB.